In recent years, with the introduction of biologic therapies for the treatment of severe asthma, there has been a shift in the goals of asthma management, from control to remission; although remission is not a cure, it is a meaningful, relevant patient-oriented outcome [1]. However, the definition of asthma remission is evolving [2] and varies across studies [3–5]. In addition, the associated factors and determinants of asthma remission are not yet completely understood. Nevertheless, there is no doubt that remission (irrespective of its definition) can be achieved in a proportion of patients with severe asthma under treatment with biologics [3–5], something until recently deemed unattainable.

Once considered unattainable, the personalised application of the most suitable biologic therapy for each patient with severe asthma allows us to effectively alleviate and, in some cases, eliminate, the burden of the disease https://bit.ly/47YcdNo